Predict your next investment

See what CB Insights has to offer

About Visionary Therapeutics

Visionary Therapeutics Corporation is a specialty pharmaceuticals company focused on nanotechnology for development of new ocular therapeutics. Its core technology is cell-penetrating dendrimers. The company's polyguanidilyate dendrimeric translocators are designed to penetrate epithelial cells to deliver small to large molecules.

Visionary Therapeutics Headquarter Location

11851 Rexmoor Drive

Richmond, Virginia, 23236,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.